Literature DB >> 16227653

Hemodynamic effect of propofol in enalapril-treated hypertensive patients during induction of general anesthesia.

Małgorzata Malinowska-Zaprzałka1, Marzena Wojewódzka, Dorota Dryl, Stanisława Z Grabowska, Ewa Chabielska.   

Abstract

Angiotensin converting enzyme inhibitor (ACE-I) treated hypertensive patients are well known to be at risk during general anesthesia, because of hypotension that can occur. We compared hemodynamic changes in these patients during induction of general anesthesia with propofol and etomidate - two intravenous anesthetics. Hypotension after propofol that we observed in ACE-I group versus normotension after etomidate (p < 0.001) in our opinion may be the result of additive effect of similar endothelium-dependent mechanism of action of propofol and ACE-I, i.e. increase in production and release of nitric oxide (NO). This very unique observation, however, needs further investigation to precisely define the mechanism of our finding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227653

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  6 in total

1.  Propofol Versus Thiopental for Rapid-Sequence Induction in Isolated Systolic Hypertensive Patients: A Factorial Randomized Double-Blind Clinical Trial.

Authors:  Nesrin Ahu Aslan; Çağıl Vural; Ali Abbas Yılmaz; Zekeriyya Alanoğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-08-17

2.  Vascular aging and hemodynamic stability in the intraoperative period.

Authors:  Ferrante S Gragasin; Stephane L Bourque; Sandra T Davidge
Journal:  Front Physiol       Date:  2012-04-02       Impact factor: 4.566

3.  Effect of pre-operative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists on intra-operative arterial pressures after induction of general anesthesia.

Authors:  Rajesh Rajgopal; Sunil Rajan; Kavitha Sapru; Jerry Paul
Journal:  Anesth Essays Res       Date:  2014 Jan-Apr

4.  Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats.

Authors:  Marzena Wojewodzka-Zelezniakowicz; Wioleta Kisiel; Karol Kramkowski; Anna Gromotowicz-Poplawska; Agnieszka Zakrzeska; Adrian Stankiewicz; Patrycjusz Kolodziejczyk; Janusz Szemraj; Jerzy Robert Ladny; Ewa Chabielska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-05-11       Impact factor: 1.636

5.  Prevention of etomidate-induced myoclonus: which is superior: Fentanyl, midazolam, or a combination? A Retrospective comparative study.

Authors:  Ilke Isitemiz; Sinan Uzman; Mehmet Toptaş; Ayşe Vahapoglu; Yaşar Gökhan Gül; Ferda Yilmaz Inal; Ibrahim Akkoc
Journal:  Med Sci Monit       Date:  2014-02-16

6.  A randomized controlled trial comparing methohexital and propofol for induction in patients receiving angiotensin axis blockade.

Authors:  Anthony Bonavia; Thomas Verbeek; Sanjib Adhikary; Allen Kunselman; Arne Budde; Jerome Lyn-Sue; Berend Mets
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.